Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT04143243 |
Other study ID # |
D3117-R |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 1, 2020 |
Est. completion date |
August 3, 2024 |
Study information
Verified date |
January 2024 |
Source |
VA Office of Research and Development |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Mild traumatic brain injury (mTBI) is the signature wound of Veterans returning from the
operations in Iraq and Afghanistan (i.e., OIF/OEF/OND), with up to 20 percent experiencing
persistent post-concussive symptoms. Among Veterans with mTBI, the majority also experience
stress-based psychopathology (e.g., depression, post-traumatic stress disorder, and/or
generalized anxiety disorder) and chronic pain. To cope with distress, pain, and other
difficulties, Veterans often turn to maladaptive avoidant coping strategies which offer short
term relief but exacerbate/maintain mental health problems and have detrimental long-term
effects on social, occupational, and community reintegration. Unfortunately, Veterans face
important barriers to seeking mental health treatment, including stigma and logistical
issues. This proposal aims to examine 1) the impact of a Veteran-centered, non-stigmatizing,
1-day "life skills group workshop" on overall distress and reintegration; and 2) the
mechanisms by which this treatment might work as well as possible influences on treatment
efficacy.
Description:
Traumatic brain injury (TBI) is the signature wound of Veterans returning from Operations
Iraqi Freedom, Operation Enduring Freedom and Operation New Dawn (OIF/OEF/OND), with up to 20
percent exposed to a mild TBI (mTBI) and experiencing persistent post-concussive symptoms.
Among those with a mTBI diagnosis, the majority also suffers from stress-based
psychopathology (e.g., depression, post-traumatic stress disorder, generalized anxiety
disorder), as well as chronic pain. To cope with distress, pain, and other difficulties,
Veterans often turn to maladaptive avoidant coping strategies which offer short term relief
but exacerbate/maintain mental health problems and have detrimental long-term effects on
social, occupational, and community reintegration. Unfortunately, Veterans face significant
barriers to engaging in mental health treatment, including stigma, the belief that one should
overcome psychological difficulties on his/her own, and concern that receiving such care
would negatively impact their careers. Practical barriers, including time constraints,
distance from a treatment facility, and competing priorities (e.g., work and family demands),
are also barriers to care. Even among Veterans who start mental health treatment, only a
small minority complete a recommended course of evidence-based therapy.
Acceptance and Commitment Therapy (ACT) is a trans-diagnostic treatment model that helps
patients to overcome avoidance by promoting acceptance-based coping and engagement in
meaningful life activities. In this context, Veterans are asked to think about their "new
mission(s)" after leaving the military and the importance of engaging in actions that fulfill
their mission even when it may be difficult. ACT has established efficacy in the treatment of
depression, anxiety, and chronic pain, and has been effectively implemented in various
treatment-delivery formats, including 1-day group workshops. A 1-day ACT workshop addresses
specific needs of Veterans with mTBI, stress-based psychopathology, and chronic pain
(polytrauma triad) and important barriers to treatment. It 1) is trans-diagnostic (i.e.,
applies to more than one condition); 2) targets avoidance-based coping; 3) cultivates
acceptance-based coping and builds on Veteran's values and goals to motivate them to make
difficult decisions; 4) is delivered efficiently and thus more accessible; 5) is less
stigmatizing and thus acceptable; and 6) address problems with treatment adherence and
completion.
With the support of an RR&D SPiRE pilot grant, the PIs developed a 1-day 'ACT on Life'
workshop tailored specifically for the needs of Veterans with mTBI, stress-based
psychopathology, and chronic pain. Veterans with this polytrauma were then randomly assigned
to the 'ACT on Life' workshop (N=20) or to Treatment as Usual (TAU; N=12). All Veterans
attending the 1-day ACT workshop completed it, and relative to TAU, exhibited greater
improvements in distress and reintegration at the 3-month follow-up (effect sizes .68 and
.47, respectively). Building on these promising preliminary findings, the investigators now
propose to conduct a more rigorous randomized controlled trial with 212 Veterans to compare
the efficacy of the 1-day ACT workshop to an active treatment comparison (Education,
Resources, and Support; ERS) on symptoms of distress and social, occupational, and community
reintegration. The investigators will also examine mediators and moderators of treatment
response to identify which ACT components are directly responsible for treatment
effectiveness and whether treatment benefits are constrained by various personal factors.
Establishing the efficacy of a 1-day ACT workshop for OEF/OEF/OND Veterans with mTBI and
multiple coexistent conditions addresses key priorities of VHA RR&D: 1. developing
interventions which will improve the psychological health status of Veterans who have
specific needs; and 2. enhancing the community, social, and occupational reintegration and
functioning of post-deployment Veterans so that they may function more fully in society.